WORK Medical Technology Group LTD announced on September 25, 2025, that it entered into an agreement with several investors for a registered direct offering. The offering involves the purchase and sale of 38,999,334 Class A ordinary shares, or pre-funded warrants in lieu thereof.
The purchase price for these shares was set at $0.075 per share. The gross proceeds to the company from this offering are expected to be approximately $2.9 million.
The transaction is expected to close on or about September 26, 2025, subject to customary closing conditions. This offering is being made pursuant to a shelf registration statement on Form F-3.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.